Researchers demonstrated AI could detect early laryngeal cancer from voice recordings, distinguishing it from benign conditions.
Key Details
- 1Laryngeal cancer affects over 1 million people worldwide, with high mortality rates.
- 2Diagnosis currently requires invasive endoscopy and biopsy; voice-based screening could simplify detection.
- 3The study analyzed 12,523 voice samples from 306 participants using the Bridge2AI-Voice dataset.
- 4Significant differences in acoustic features, especially harmonic-to-noise ratio, identified laryngeal cancer in men.
- 5Findings suggest voice could serve as a practical biomarker for cancer risk assessment, pending further validation.
Why It Matters
A non-invasive, AI-based screening tool for laryngeal cancer could enable earlier detection, reducing diagnostic delays and easing burden on specialists. This advances the potential of digital biomarkers and broadens the scope of imaging AI in oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.